TuHURA Biosciences, Inc. HURA
1.39 USD -0.06 (-4.14%)
Regular-session close
1.39 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
1.36 Day range 1.53
0.44 52-week range 3.15
- YTD
- +83.62%
- 1 year
- -31.86%
Analyst view
Price target (mean) 15.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Revenue and earnings: history and forecast
What HURA reported, and what analysts expect for the next two fiscal years
Earnings per share
Analysts expect earnings per share of -0.41 in the current fiscal year.
Fiscal years. Estimates are the analyst consensus and change as analysts revise them; the percentages are the change on the year before. Earnings per share is on the basis analysts estimate, which can differ from the reported (GAAP) figure.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09 | -0.09 – -0.09 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next quarter | -0.10 | -0.10 – -0.10 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Current year | -0.41 | -0.41 – -0.41 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next year | -0.42 | -0.42 – -0.42 | -0.41 | -2.4% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | Rodman & Renshaw | Initiated | — | Buy |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
